In summary, our findings demonstrated that rhabdomyolysis resulted in the increase of FABP4 in tubular epithelial cells and pharmacological inhibition of FABP4 activity by BMS309403 protected against rhabdomyolysis-induced AKI via the regulation of ER stress and inflammation in tubular epithelial cells. Here, FABP4 is linked to rhabdomyolysis.